Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

ClinicalTrials.gov ID: NCT01532414

Public ClinicalTrials.gov record NCT01532414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled Multi-Center Phase III Study to Evaluate Normalization of Morning Testosterone Levels in Overweight Men With Acquired Hypogonadotropic Hypogonadism and Normal Sperm Concentration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of ZA-301 is to determine the effects of Androxal on morning testosterone and reproductive status in younger overweight men with acquired hypogonadotropic hypogonadism (confirmed morning T\<300 ng/dL) and normal sperm concentration, compared to changes with placebo. Subjects must not have previously been treated with testosterone products within the last 6 months.

Study identification

NCT ID
NCT01532414
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Repros Therapeutics Inc.
Industry
Enrollment
151 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2012 (Type not available)
Primary completion
Mar 2013 (Actual)
Completion
Mar 2013 (Actual)
Last update posted
May 27, 2015

2012 – 2013

United States locations

U.S. sites
23
U.S. states
11
U.S. cities
22
Facility City State ZIP Site status
Coastal Clinical Research Mobile Alabama 36608 —
Baptist Health Center for Clinical Research Little Rock Arkansas 72205 —
SC Clinical Research Garden Grove California 92844 —
Mission Internal Medicine Group Mission Viejo California 92691 —
Rancho Cucamonga Clinical Trials Rancho Cucamonga California 91730 —
San Diego Sexual Medicine San Diego California 92120 —
West Coast Clinical Research Tarzana California 91356 —
Florida Fertility Institute Clearwater Florida 33759 —
Tampa Bay Medical Research Clearwater Florida 33761 —
ALL Medical Research Cooper City Florida 33024 —
Clinical Research of South Florida Coral Gables Florida 33134 —
Therafirst Medical Center Fort Lauderdale Florida 33308 —
Well Pharma Medical Research Group Miami Florida 33143 —
Phase One Solutions Miami Gardens Florida 33169 —
Meridien Research St. Petersburg Florida 33709 —
Central Kentucky Research Associates Lexington Kentucky 40509 —
Clinical Research Advantage Henderson Nevada 89052 —
Premier Urology Associates Lawrenceville New Jersey 08648 —
Rochester Clinical Research Rochester New York 14609 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
New Orleans Center for Clinical Research Knoxville Tennessee 37920 —
Lone Peak Family Medicine Draper Utah 84020 —
Granger Medical Clinic West Valley City Utah 84120 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01532414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 27, 2015 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01532414 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →